Nu Skin Enterprises, Inc. (NUS) posted dismal third-quarter 2024 results, with the top and bottom lines missing Zacks Consensus Estimate. Earnings and net sales declined year over year amid macroeconomic pressure and challenges in the direct selling industry. Taking into account persistent pressure in the core Nu Skin business, management is lowering its 2024 outlook.In the third quarter, Nu Skin posted adjusted earnings of 17 cents a share, excluding inventory write-off, restructuring and impairment impact ...